Related Experiment Videos
Symptomatic benign breast disease and hormone replacement therapy
D T Finkelde1, P R Kitchen, P R Hayes
1University of Melbourne Department of Surgery and Breast Unit, St Vincent's Hospital, Melbourne, Victoria, Australia.
Breast (Edinburgh, Scotland)
|February 18, 2004
Summary
Hormone replacement therapy (HRT) did not alter how post-menopausal women present with breast symptoms or their final diagnoses. This study found no significant difference in breast disease presentation or outcomes between HRT users and non-users.
Area of Science:
- Oncology
- Endocrinology
- Women's Health
Background:
- Hormone replacement therapy (HRT) is commonly used by post-menopausal women.
- Concerns exist regarding HRT's potential influence on breast health and disease presentation.
- Understanding HRT's impact is crucial for accurate diagnosis and patient management.
Purpose of the Study:
- To investigate the effect of HRT on the presentation and diagnoses of breast conditions in post-menopausal women.
- To compare breast clinic presentation patterns between HRT users and non-users.
- To determine if HRT influences the likelihood of benign breast disease.
Main Methods:
- Retrospective review of patients presenting to a symptomatic Breast Clinic over a 5-year period.
- Comparison of 67 post-menopausal women (age <65) on HRT for >6 months with 144 post-menopausal women (age <65) not on HRT.
- Analysis of presentation patterns, intervention rates, and final diagnoses.
Main Results:
- No significant difference was observed in the pattern of breast symptom presentation between the HRT and non-HRT groups.
- The rate of clinical intervention (e.g., biopsy) did not differ between the two groups.
- Final diagnoses, including benign breast disease, showed no statistically significant variation between HRT users and non-users.
Conclusions:
- Hormone replacement therapy (HRT) does not appear to affect the presentation patterns of symptomatic breast conditions in post-menopausal women.
- HRT use is not associated with altered rates of intervention or specific diagnoses in this patient cohort.
- Further research may explore long-term effects, but current findings suggest HRT does not mask or alter typical benign breast disease presentations.